A 2023 meta-analysis in JAMA Internal Medicine found a possible association with medullary thyroid carcinoma specifically, but the absolute risk remained very low
While each plan is individualised, here are some common combination approaches we find effective: For Patients Just Starting GLP-1 Medications Primary Focus : Prevention and Preservation Common Treatment Combination : Foundation : Sculptra or Juvelook treatment to stimulate collagen production before significant volume loss Integration : Often combined in the same session with minimal strategic filler in key support areas Enhancement : Typically followed by Fotona 4D Lift 2-3 weeks later to optimise tissue response Progression : Subsequent treatments mix additional biostimulators with targeted energy treatments based on your weight loss pace and facial changes This preventative approach allows us to stay ahead of facial changes, rather than chasing them after they appear
Our program is designed to be flexible and supportive, connecting you with licensed providers who can help navigate these everyday health hurdles
The pharmacokinetic profile is well-established through extensive clinical trials
Several clinical trials conducted in the 1990s examined the effect of acetyl-L-carnitine (ALCAR) treatment on the cognitive performance of patients clinically diagnosed with Alzheimer's disease
Get baseline bloodwork including comprehensive metabolic panel, lipid panel, HbA1c, thyroid panel, and inflammatory markers